Cargando…
Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease
PURPOSE: To evaluate serum cortistatin (CST) levels in type 2 diabetes mellitus (T2DM) patients with or without non-alcoholic fatty liver disease (NAFLD) and to examine the relationship between CST and NAFLD. METHODS: A total of 90 T2DM patients, which included 56 NAFLD patients (referred to as DM+N...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960706/ https://www.ncbi.nlm.nih.gov/pubmed/36851999 http://dx.doi.org/10.2147/IJGM.S396315 |
_version_ | 1784895575517298688 |
---|---|
author | Sun, Tiantian Wang, Chang Huo, Lijing Wang, Yichao Liu, Ke Wei, Changmei Zhao, Hang Chen, Shuchun Ren, Luping |
author_facet | Sun, Tiantian Wang, Chang Huo, Lijing Wang, Yichao Liu, Ke Wei, Changmei Zhao, Hang Chen, Shuchun Ren, Luping |
author_sort | Sun, Tiantian |
collection | PubMed |
description | PURPOSE: To evaluate serum cortistatin (CST) levels in type 2 diabetes mellitus (T2DM) patients with or without non-alcoholic fatty liver disease (NAFLD) and to examine the relationship between CST and NAFLD. METHODS: A total of 90 T2DM patients, which included 56 NAFLD patients (referred to as DM+NAFLD group) and 34 patients without NAFLD (DM-only group), and 83 non-diabetes individuals that included 39 NAFLD patients (NAFLD-only group) and 44 without NAFLD that acted as the normal-control group (NC group). The differences in the serum CST levels between the groups were compared, and the correlations between CST and other variables were calculated by applying both correlational analysis and multiple linear regression analysis. RESULTS: The mean serum CST levels were significantly lower in the DM+NAFLD and DM groups than in the NC group (P < 0.05). In addition, the CST levels were lower in the DM group relative to that in the NAFLD group (P < 0.05). However, no statistical difference was noted in the serum CST between diabetic patients with and without NAFLD (P > 0.05). Similarly, in the non-diabetic group, the serum CST level was not significantly different between individuals with and without NAFLD (P > 0.05). Furthermore, the serum CST levels were negatively associated with the levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), fasting plasma glucose (FPG), homeostasis model assessment-insulin resistance (HOMA-IR), and insulin cell function index (HOMA-β). Conversely, the serum CST levels were positively associated with high-density lipoprotein cholesterol (HDL-C). The data obtained through multiple linear regression implied that LDL-C and HOMA-β, but not HOMA-IR, were closely related to serum CST levels. CONCLUSION: T2DM was related to decreased serum CST. However, serum CST was correlated with HOMA-β in T2DM patients, while HOMA-IR was not. There was no correlation between CST and NAFLD. |
format | Online Article Text |
id | pubmed-9960706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-99607062023-02-26 Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease Sun, Tiantian Wang, Chang Huo, Lijing Wang, Yichao Liu, Ke Wei, Changmei Zhao, Hang Chen, Shuchun Ren, Luping Int J Gen Med Original Research PURPOSE: To evaluate serum cortistatin (CST) levels in type 2 diabetes mellitus (T2DM) patients with or without non-alcoholic fatty liver disease (NAFLD) and to examine the relationship between CST and NAFLD. METHODS: A total of 90 T2DM patients, which included 56 NAFLD patients (referred to as DM+NAFLD group) and 34 patients without NAFLD (DM-only group), and 83 non-diabetes individuals that included 39 NAFLD patients (NAFLD-only group) and 44 without NAFLD that acted as the normal-control group (NC group). The differences in the serum CST levels between the groups were compared, and the correlations between CST and other variables were calculated by applying both correlational analysis and multiple linear regression analysis. RESULTS: The mean serum CST levels were significantly lower in the DM+NAFLD and DM groups than in the NC group (P < 0.05). In addition, the CST levels were lower in the DM group relative to that in the NAFLD group (P < 0.05). However, no statistical difference was noted in the serum CST between diabetic patients with and without NAFLD (P > 0.05). Similarly, in the non-diabetic group, the serum CST level was not significantly different between individuals with and without NAFLD (P > 0.05). Furthermore, the serum CST levels were negatively associated with the levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), fasting plasma glucose (FPG), homeostasis model assessment-insulin resistance (HOMA-IR), and insulin cell function index (HOMA-β). Conversely, the serum CST levels were positively associated with high-density lipoprotein cholesterol (HDL-C). The data obtained through multiple linear regression implied that LDL-C and HOMA-β, but not HOMA-IR, were closely related to serum CST levels. CONCLUSION: T2DM was related to decreased serum CST. However, serum CST was correlated with HOMA-β in T2DM patients, while HOMA-IR was not. There was no correlation between CST and NAFLD. Dove 2023-02-21 /pmc/articles/PMC9960706/ /pubmed/36851999 http://dx.doi.org/10.2147/IJGM.S396315 Text en © 2023 Sun et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Sun, Tiantian Wang, Chang Huo, Lijing Wang, Yichao Liu, Ke Wei, Changmei Zhao, Hang Chen, Shuchun Ren, Luping Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease |
title | Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease |
title_full | Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease |
title_fullStr | Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease |
title_full_unstemmed | Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease |
title_short | Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease |
title_sort | serum cortistatin level in type 2 diabetes mellitus and its relationship with nonalcoholic fatty liver disease |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960706/ https://www.ncbi.nlm.nih.gov/pubmed/36851999 http://dx.doi.org/10.2147/IJGM.S396315 |
work_keys_str_mv | AT suntiantian serumcortistatinlevelintype2diabetesmellitusanditsrelationshipwithnonalcoholicfattyliverdisease AT wangchang serumcortistatinlevelintype2diabetesmellitusanditsrelationshipwithnonalcoholicfattyliverdisease AT huolijing serumcortistatinlevelintype2diabetesmellitusanditsrelationshipwithnonalcoholicfattyliverdisease AT wangyichao serumcortistatinlevelintype2diabetesmellitusanditsrelationshipwithnonalcoholicfattyliverdisease AT liuke serumcortistatinlevelintype2diabetesmellitusanditsrelationshipwithnonalcoholicfattyliverdisease AT weichangmei serumcortistatinlevelintype2diabetesmellitusanditsrelationshipwithnonalcoholicfattyliverdisease AT zhaohang serumcortistatinlevelintype2diabetesmellitusanditsrelationshipwithnonalcoholicfattyliverdisease AT chenshuchun serumcortistatinlevelintype2diabetesmellitusanditsrelationshipwithnonalcoholicfattyliverdisease AT renluping serumcortistatinlevelintype2diabetesmellitusanditsrelationshipwithnonalcoholicfattyliverdisease |